Viewing nowSenrica 150 mg Tablets (Pregabalin)
Pregabalin 150mg
Tablet · Prescription medication
Ilsung IS Co., Ltd.

MFDS item code 201706650 · Approved 2017.08.18 · Insurance code 655403820
Relief of peripheral and central neuropathic pain, adjunctive treatment for partial seizures, improvement of fibromyalgia
This medication is used to treat peripheral and central neuropathic pain in adults. It is also effective as an adjunct for patients with epilepsy experiencing partial seizures, helping in cases with or without generalized symptoms. Additionally, it is used to improve symptoms of fibromyalgia. This drug aids in relieving various neurological disorders and pain symptoms.
This medication is taken orally, divided into two doses daily regardless of meals. 1. Neuropathic pain - Peripheral neuropathic pain: Initial dose of 150 mg per day, may increase to 300 mg per day after 3 to 7 days, and if necessary, may be increased to a maximum of 600 mg at 7-day intervals. - Central neuropathic pain: Initial dose of 150 mg per day, may increase to 300 mg per day after one week and additional increase after another week.
The use of this medication is not recommended for pediatric patients under the age of 12 and for adolescents aged 12 to 17 due to insufficient safety and efficacy data.
This medication may increase the risk of suicidal thoughts and behaviors, so if mood changes or abnormal behavior occur during treatment, it should be reported to a healthcare professional immediately. It should not be used if there is hypersensitivity to any of its ingredients. Patients with diabetes may experience weight gain while on this medication, necessitating adjustments in their blood sugar control medications. If symptoms of angioedema occur, the medication should be stopped immediately and the patient should consult a healthcare professional. Elderly patients may experience increased dizziness or drowsiness when taking this medication and should take caution; particular care is needed in the early stages of treatment. Transient blurred vision or changes in vision may occur, and it is advisable to inform a healthcare professional if symptoms arise. Abrupt discontinuation of this medication can result in withdrawal symptoms such as insomnia, headache, and anxiety; it should therefore be gradually reduced in consultation with a healthcare professional. Patients with a history of substance abuse may be at risk of dependence on this medication and should exercise caution while taking it. Patients with impaired kidney function may require dosage adjustments, and if changes in kidney function occur, they should consult a healthcare professional. Patients with heart disease or congestive heart failure should be cautious when taking this medication. Caution is also advised when taking this medication with other CNS depressants, as it can increase the risk of drowsiness or respiratory depression. During pregnancy, especially in the first three months, it may pose risks to the fetus; women who are pregnant or planning to become pregnant should consult a healthcare professional and use effective contraception. Breastfeeding women should consider discontinuing breastfeeding or the medication as it may pass into breast milk, and safety for infants has not been established. This medication can cause dizziness and drowsiness, so driving or operating hazardous machinery should be avoided at the beginning of treatment. Severe skin reactions can rarely occur; if skin rash, redness, or blisters appear, discontinue use and inform a healthcare professional immediately. In cases of overdose, symptoms such as confusion, drowsiness, and depression may occur, and emergency measures such as hemodialysis may be needed if necessary. Keep out of reach of children, and transferring to another container can pose risks of accidents and quality degradation, so caution is advised.
Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of skin or eyes), extreme drowsiness, sudden and severe headache, thunderclap headache, seizures, disorientation, visual disturbances, paralysis,
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is also important to keep the medication in a cool place, maintaining a room temperature between 1 and 30 degrees Celsius. Proper storage will help preserve the effectiveness of the medication for a longer time.
White or pale yellow round tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Tablet · Prescription medication
Ilsung IS Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.